RecruitingPhase 2NCT05828069
Immune
Langerhans cell histiocytosis
58
studies recruiting now
as of 7 Sept 2026
269
studies registered in total
as of 7 Sept 2026
4
countries with a recruiting site
as of 7 Sept 2026
2 Sept 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT02254863
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
RecruitingNCT07800234
Establishing a National Egyptian HLH Registry (NEHR)
RecruitingNCT05588167
Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C
RecruitingNCT00344331
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 58 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Langerhans cell histiocytosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Langerhans cell histiocytosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (MAP2K1, NRAS, BRAF).
Treatments being studied
13 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Prednisone (Cortan)
Phase 3Vinblastine
Phase 3Cytarabine (Alexan)
Phase 2Afuresertib
Phase 2Clofarabine (Clolar)
Phase 2Trametinib (Mekinist)
Phase 2Thalidomide (Kevadon)
Phase 2Thioguanine (Lanvis)
+ 5 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).